EDGAR Filing Documents for 0001193125-24-081596

Form S-8 - Securities to be offered to employees in employee benefit plans:

SEC Accession No. 0001193125-24-081596

Filing Date

2024-03-29

Accepted

2024-03-29 09:06:08

Documents

Effectiveness Date

2024-03-29

Document Format Files

Seq	Description	Document	Type	Size
1	S-8	d800198ds8.htm	S-8	39085
2	EX-5.1	d800198dex51.htm	EX-5.1	9063
3	EX-23.2	d800198dex232.htm	EX-23.2	1518
4	EX-FILING FEES	d800198dexfilingfees.htm	EX-FILING FEES	21095
5	GRAPHIC	g800198g001.jpg	GRAPHIC	2112
6	GRAPHIC	g800198g002.jpg	GRAPHIC	2142
	Complete submission text file	0001193125-24-081596.txt		77903

Mailing Address 480 ARSENAL WAY, SUITE 100 WATERTOWN MA 02472

Business Address 480 ARSENAL WAY, SUITE 100 WATERTOWN MA 02472 617-207-8979

Acrivon Therapeutics, Inc. (Filer) CIK: 0001781174 (see all company filings)

IRS No.: 825125532 | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-278365 | Film No.: 24802222
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)